The Kinetics of Hepatitis C Virus-Specific CD8 T-Cell Responses in the Blood Mirror Those in the Liver in Acute Hepatitis C Virus Infection

ABSTRACT Peripheral blood T-cell responses are used as biomarkers in hepatitis C virus (HCV) vaccine trials. However, it is not clear how T-cell responses in the blood correlate with those in the liver, the infection site. By studying serial liver and blood samples of five vaccinated and five mock-vaccinated control chimpanzees during acute HCV infection, we demonstrate a correlation between HCV-specific CD8 T-cell responses in the blood and molecular and functional markers of T-cell responses in the liver. Thus, HCV-specific CD8 T-cell responses in the blood are valid markers for intrahepatic T-cell activity.

[1]  B. Rehermann,et al.  Immunological techniques in viral hepatitis. , 2007, Journal of hepatology.

[2]  A. Folgori,et al.  A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees , 2006, Nature Medicine.

[3]  J. North,et al.  Ligation of CD8α on human natural killer cells prevents activation‐induced apoptosis and enhances cytolytic activity , 2005, Immunology.

[4]  B. Rehermann,et al.  Immunology of hepatitis B virus and hepatitis C virus infection , 2005, Nature Reviews Immunology.

[5]  S. Ray,et al.  Cross-Genotype Immunity to Hepatitis C Virus , 2004, Journal of Virology.

[6]  J. Ghrayeb,et al.  Memory CD8+ T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection , 2003, The Journal of experimental medicine.

[7]  C. Rice,et al.  Kinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees , 2003, Journal of Virology.

[8]  L. Wodicka,et al.  Genomic analysis of the host response to hepatitis C virus infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Purcell,et al.  Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  F. Chisari,et al.  Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection , 2001, The Journal of experimental medicine.

[11]  R. Lanford,et al.  DNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection , 2001, Journal of Virology.

[12]  M. Houghton,et al.  Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection , 2001, Hepatology.

[13]  B. Walker,et al.  Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus , 2000, The Journal of experimental medicine.

[14]  M. Manns,et al.  Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C , 2000, Nature Medicine.

[15]  T. Santantonio,et al.  Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection , 1995, The Lancet.

[16]  B. Walker,et al.  Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. , 1992, Journal of immunology.

[17]  M. Hanlon,et al.  Hepatitis C Vaccines: Inducing and Challenging Memory T Cells , 2006 .

[18]  H J Alter,et al.  Recovery, Persistence, and Sequelae in Hepatitis C Virus Infection: A Perspective on Long-Term Outcome , 2000, Seminars in liver disease.

[19]  M. Houghton.  Strategies and prospects for vaccination against the hepatitis C viruses. , 2000, Current topics in microbiology and immunology.

[20]  J. Parnes.  Molecular biology and function of CD4 and CD8. , 1989, Advances in immunology.